Lasa Supergenerics Limited — Results, 13-02-2026: Integrated Filing- Financial

LASA Supergenerics' board has approved its Q3 FY26 financial results, which highlight the severe impact of a factory fire in May 2025. This incident has completely halted production at its key manufacturing unit. Crucially, the affected assets were uninsured, leading to substantial exceptional losses: inventories worth ₹12.74 Cr, property and equipment of ₹7.00 Cr, and other expenses of ₹0.84 Cr. The company is exploring alternative manufacturing options as operations remain suspended. This operational standstill and uninsured losses point to a very challenging period for the company.